IMUC - PP$/Volume Spike following today's presentation.Price and volume continue to build heading to 52wk hi
IMUC ImmunoCellular Therapeutics to Present at the 13th Annual BIO CEO & Investor Conference 8:00 am ET 02/11/2011- Business Wire LOS ANGELES--(BUSINESS WIRE)--Feb. 11, 2011-- ImmunoCellular Therapeutics, Ltd. (OTCBB: IMUC), a biotechnology company that is developing immune-based therapies for the treatment of various forms of cancer, announced today that Manish Singh, Ph.D., the company's chief executive officer, will deliver a corporate overview at the upcoming 13th Annual BIO CEO & Investor Conference at the Waldorf Astoria in New York City. Dr. Singh's presentation will take place on Monday, February 14, 2011 at 2:30 p.m. on the 4th Floor.